VRDN Viridian Therapeutics, Inc.
$21.24▼ -4.71%
Healthcare
Other
After hours
$21.40▲ +0.75%
Sep 11, 7:54 PM ET
Volume 943.2K
Avg Volume (10D) 1.19M
Key Metrics & Fundamentals
Market Cap
$2.41B
P/E Ratio
–
Div Yield
–%
52W Range
13.18 - 34.29
% vs 50 MA
-0.73%
% vs 200 MA
-10.17%
RSI-14
38.7
MACD Histogram
-0.3800
Beta (1Y vs SPY)
1.09
Free Cash Flow
-$106.63M
Gross Rev
$284,000
Gross Profit
$284,000
EBITDA
-$117.51M
COGS
–
Operating Exp
$126.55M
Operating Income
-$126.27M
EBIT
-$126.27M
Pretax Income
-$127.12M
Net Income
-$127.12M
EPS (Diluted)
-1.05
Price & Volume History
Loading chart…
Recent News
Viridian Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
Business Wire · Sep 2, 2026 8:00 PM
Viridian Therapeutics to See 'Minimal' Revenue Growth in H2, RBC Capital Markets Says
MT Newswires · Aug 7, 2026 4:05 PM
RBC Adjusts Viridian Therapeutics PT to $36 From $35, Maintains Outperform Speculative Risk Rating
MT Newswires · Aug 7, 2026 1:28 PM
Wedbush Adjusts PT on Viridian Therapeutics to $41 From $43, Maintains Outperform Rating
MT Newswires · Aug 6, 2026 1:43 PM
Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results
Business Wire · Aug 6, 2026 11:01 AM
Graves Ophthalmopathy Market Expected to Witness Rapid Expansion at a CAGR of 9% During the Forecast Period (2026-2036), Driven by the Recent Approval of Viridian's LUMVOA and the Launch of Emerging Therapies | DelveInsight
PR Newswire · Jul 29, 2026 2:31 PM
Lumvoa’s Unique Profile Leads to Optimism Around Viridian Therapeutics (VRDN)
Insider Monkey · Jul 15, 2026 2:01 PM
Viridian Therapeutics (VRDN) Rebounds Sharply, Is The Valuation Still Too Rich?
Simply Wall St. · Jul 15, 2026 12:24 PM
Viridian Therapeutics (VRDN) Stock Still Looks Above Fair Value Today
Simply Wall St. · Jul 15, 2026 5:10 AM
“Stay Invested”: Wells Fargo Picks 2 Stocks to Buy as It Stays Bullish on the Market
TipRanks · Jul 14, 2026 5:55 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See VRDN's money flow as a full page
Social Sentiment
Avg +1.00 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.